KOA Biotech closes a 2M round led by Swanlaab

KOA Biotech is a biotech startup, born as a spin-off of Pompeu Fabra University (Barcelona), based on the doctoral thesis of its founder, Sira Mogas. The company develops solutions for the aquaculture sector, specifically it has a solution for early detection of infections in fish farms. The €2 million round has been led by Swanlaab Innvierte Agrifood-Tech , with the participation of the Fund-F (Austria) and FABER (Portugal) funds.

More than half of the fish we consume comes from aquaculture production, however, as Sira Mogas, CEO and founder of KOA , pointed out, “ infections in fish farms are a growing problem, resulting in the loss of up to 30% of production in these farms (estimated from an economic point of view at a global level at more than $6 billion).”

Infections in fish farms result in the loss of up to 30% of production. KOA Biotech can help

Using biotechnological tools, KOA Biotech has developed a system of biosensors, which are combined with proprietary algorithms, in an autonomous device capable of early detection of infections in water, which allows preventive measures to be taken in production systems that prevent the spread of infections in water, and reduce mortality from infectious pathogens and the use of antibiotics in fish farms.

Optimizing the use of natural resources, reducing environmental impact and addressing critical challenges such as production, food security and climate change.

Among the reasons that have led Swanlaab to trust KOA Biotech, its innovative technology stands out, which allows for the optimisation of the use of natural resources, reducing environmental impact and addressing critical challenges such as production, food safety and climate change.

As Nora Alonso, General Partner of Swanlaab Innvierte Agrifood-Tech, pointed out, “investing in technological and innovative companies such as KOA is key to the development and enhancement of the research carried out in this sector in Spain, and a lever for the development and differentiation of the country’s agri-food sector, with an impact at a global level. In addition, it is an opportunity to attract foreign investment in this sector, as is the case of KOA, which has the participation of the two international impact funds Fund-F and FABER in this round of investment.”

This round of investment will allow KOA Biotech to advance technological development and consolidate technology in the sector, and to launch its business plan.

__

(Featured image by Hanson Lu via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in tech food. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us